上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。
Volasertib trihydrochloride (Synonyms: 伏拉塞替三盐酸盐; BI 6727 trihydrochloride)
Volasertib (BI 6727) trihydrochloride 是一种具有口服活性的、高效的、ATP 竞争性的 Polo 样激酶 1 (PLK1) 抑制剂，IC50 为 0.87 nM。Volasertib trihydrochloride 抑制 PLK2 和 PLK3，IC50 分别为 5 和 56 nM。Volasertib trihydrochloride 诱导有丝分裂停滞和细胞凋亡。Volasertib trihydrochloride 是一种二氢蝶呤酮衍生物，在多种癌症模型中显示出显着的抗肿瘤活性。
Volasertib trihydrochloride Chemical Structure
CAS No. : 946161-17-7
| 规格 |
|
是否有货 |
|
| 100 mg |
|
询价 |
|
| 250 mg |
|
询价 |
|
| 500 mg |
|
询价 |
|
* Please select Quantity before adding items.
Volasertib trihydrochloride 的其他形式现货产品:
Volasertib
| 生物活性 |
Volasertib (BI 6727) trihydrochloride is an orally active, highly potent and ATP-competitive Polo-like kinase 1 (PLK1) inhibitor with an IC50 of 0.87 nM. Volasertib trihydrochloride inhibits PLK2 and PLK3 with IC50s of 5 and 56 nM, respectively. Volasertib trihydrochloride induces mitotic arrest and apoptosis. Volasertib trihydrochloride, a dihydropteridinone derivative, shows marked antitumor activity in multiple cancer models[1][2].
|
体外研究
(In Vitro) |
Volasertib trihydrochloride (BI 6727 trihydrochloride; 0.01-10000 nM; 72 hours) has EC50 values of 11 to 37 nmol/L in multiple cell lines[1].
Volasertib trihydrochloride (10-1000 nM; 24 hours) results accumulation of cells with 4N DNA content, indicative of a cell cycle block in G2-M phase[1].
Volasertib trihydrochloride (100 nM; 24-72 hours) induces cell apoptosis at 48 hours[1].
Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.
Cell Proliferation Assay[1]
| Cell Line: |
Multiple cell lines |
| Concentration: |
0.01-10000 nM |
| Incubation Time: |
72 hours |
| Result: |
Inhibited proliferation of multiple cell lines derived from various cancer tissues, including carcinomas of the colon (HCT 116, EC50=23 nmol/L) and lung (NCI-H460, EC50=21 nmol/L), melanoma (BRO, EC50=11 nmol/L), and hematopoietic cancers (GRANTA-519, EC50=15 nmol/L; HL-60, EC50=32 nmol/L; THP-1, E50=36 nmol/L and Raji, EC50=37 nmol/L) with EC50 values of 11 to 37 nmol/L. |
Apoptosis Analysis[1]
| Cell Line: |
NCI-H460 cells |
| Concentration: |
100 nM |
| Incubation Time: |
24, 48, 72 hours |
| Result: |
G2-M arrest at 24 hours was followed by induction of apoptosis at 48 hours. |
Cell Cycle Analysis[1]
| Cell Line: |
NCI-H460 cells |
| Concentration: |
10, 30, 100, 300, 1000 nM |
| Incubation Time: |
24 hours |
| Result: |
Resulted in accumulation of cells with 4N DNA content, indicative of a cell cycle block in G2-M phase. |
|
体内研究
(In Vivo) |
Volasertib trihydrochloride (BI 6727 trihydrochloride; A total weekly dose of 50 mg/kg; Oral; once a week, twice a week, or daily; for 40 days) shows comparable efficacy in human colon carcinoma xenograft models[1].
Volasertib trihydrochloride (15, 20, or 25 mg/kg/day; i.v.; 2 consecutive days per week; for 40 days) leads to significant tumor growth delay and even tumor regression in human colon carcinoma xenograft models [1].
Volasertib trihydrochloride (70 mg/kg given once weekly or 10 mg/kg daily; oral) significantly delays tumor growth in a non-small cell lung carcinoma xenograft model derived from NCI-H460 cells[1].
Volasertib (a single dose of 40 mg/kg; iv) causes a significant (13-fold) increase in mitotic cells in HCT 116 tumor-bearing nude mice[1].
Volasertib has high volume of distribution and a long terminal half-life in mice (Vss=7.6 L/kg, t1/2=46 h) and rats (Vss=22 L/kg, t1/2=54 h)[1].
Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.
| Animal Model: |
Female BomTac:NMRI-Foxn1nu mice (Taconic) were grafted s.c. with HCT 116 human colon carcinoma cells (ATCC CCL-247)[1] |
| Dosage: |
A total weekly dose of 50 mg/kg |
| Administration: |
Oral; once a week, twice a week, or daily; for 40 days |
| Result: |
Showed comparable efficacy and were well tolerated. |
| Animal Model: |
Female BomTac:NMRI-Foxn1nu mice and male Wistar rats of the strain Crl:WI[1] |
| Dosage: |
35 mg/kg (mice) or 10 mg/kg (rat) (Pharmacokinetic Analysis) |
| Administration: |
IV 5-minute infusion; a single dose 5-minute infusion |
| Result: |
Had high volume of distribution and a long terminal half-life in mice (Vss=7.6 L/kg, t1/2=46 h) and rats (Vss=22 L/kg, t1/2=54 h). |
|
| Clinical Trial |
|
| 分子量 |
|
| Formula |
|
| CAS 号 |
|
| 中文名称 |
|
| 运输条件 |
Room temperature in continental US; may vary elsewhere.
|
| 储存方式 |
Please store the product under the recommended conditions in the Certificate of Analysis.
|
所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务
